%0 Journal Article
%T Short-term effects of lovastatin therapy on proteinuria of type 2 diabetic nephropathy: A clinical trial study
%A Aida Aharilahagh
%A Alireza Sadighi
%A Amir-Mansour Vatankhah
%A Javid Safa
%A Mohammad Naghavi-Behzad
%A Nastaran Ghodratnezhad-Azar
%A Ourmaan Nezami-Nargabad
%A Parinaz Pishahang
%A Reza Piri
%A Sanam Fakour
%A Savalan Babapoor-Farrokhran
%A Sina Davari-Farid
%A Sona Ghorashi
%J Archive of "Nigerian Medical Journal : Journal of the Nigeria Medical Association".
%D 2016
%R 10.4103/0300-1652.190600
%X Diabetic nephropathy (DN) is characterized by albuminuria, hypertension, and a progressive decline in glomerular filtration rate. The 3-hydroxy-3-methylglutaryl coenzyme A is a well-known agent that is active in lowering total plasma and low-density lipoprotein cholesterol (LDL-C) levels in cases with hypercholesterolemia. Hence, in this study, proteinuria changes at the beginning and after the withdrawal of lovastatin in patients with type 2 DN (T2DN) were studied
%K Diabetes type 2
%K nephropathy
%K proteinuria
%K statin
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5036295/